Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.
about
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.
P2860
Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@en
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@nl
type
label
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@en
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@nl
prefLabel
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@en
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@nl
P2093
P2860
P50
P356
P1476
Positive Allosteric Modulation ...... ic Deficit Models of Behavior.
@en
P2093
Christopher J Langmead
Daniel T Malone
David M Shackleford
Rahul T Patil
Shailesh N Mistry
P2860
P304
P356
10.1124/JPET.116.235788
P407
P50
P577
2016-09-14T00:00:00Z